Anti-VEGF Therapy May Aid Visual Acuity in Some nAMD Patients
Useful visual acuity preserved for about 20 percent of patients over their average remaining lifetime
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.